Ra Medical Systems Inc. (AMEX:RMED) shares traded higher over the last trading session, gaining 87.30% on 06/07/21. The shares fell to a low of $6.43 before closing at $9.14. Intraday shares traded counted 128.64 million, which was -4494.17% lower than its 30-day average trading volume of 2.80M. RMED’s previous close was $4.88 while the outstanding shares total 2.92M. The stock’s Relative Strength Index (RSI) is 87.12, with weekly volatility at 40.57% and ATR at 1.10. The RMED stock’s 52-week price range has touched low of $2.85 and a $17.00 high.
Investors have identified the Medical Devices company Ra Medical Systems Inc. as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around $41.40 million, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.
Ra Medical Systems Inc. (RMED) Fundamentals that are to be considered.
When analyzing a stock, the first fundamental thing to take into account is the balance sheet. How healthy the balance sheet of a company is will determine if the company will be able to carry out all its financial and non-financial obligations and also keep the faith of its investors. In terms of their assets, the company currently has 19.92 million total, with 5.98 million as their total liabilities.
RMED were able to record -8.1 million as free cash flow during the 08/17/2021 quarter of the year, this saw their quarterly net cash flow reduce by -7.95 million. In cash movements, the company had a total of -8.08 million as operating cash flow.
Potential earnings growth for Ra Medical Systems Inc. (RMED)
In order to determine the future investment potential for this stock, we will have to analyze key trends that affect it. During the 08/17/2021 quarter of the year, Ra Medical Systems Inc. recorded a total of 1.12 million in revenue. This figure implies that they witnessed a quarterly year/year change in their earnings with -22.9% coming in sequential stages and their sales for the 08/17/2021 quarter reducing by -8.86%.
What matters though is how it ends. When the core data for the company is broken down, then the stock sounds interesting. The company spent 1.37 million trying to sell their products during the last quarter, with the result yielding a gross income of -0.26 million. This allows shareholders to hold on to 2.92M with the recently reported earning now reading -2.48 cents per share. This is a figure that compared to analyst’s prediction for their 08/17/2021 (-2.48 cents a share).
Is the stock of RMED attractive?
In related news, Director, Stafslien Joan bought 4,410 shares of the company’s stock in a transaction that recorded on Nov 19. The purchase was performed at an average price of 5.67, for a total value of 25,002. As the purchase deal closes, the Director, COLOMBATTO MARTIN J now bought 8,700 shares of the company’s stock, valued at 50,279. Also, Director, ENQUIST WILLIAM R bought 5,263 shares of the company’s stock in a deal that was recorded on Nov 19. The shares were cost at an average price of 5.82 per share, with a total market value of 30,622. Following this completion of disposal, the Director, Mejia Richard Jr now holds 1,000 shares of the company’s stock, valued at 5,820. In the last 6 months, insiders have changed their ownership in shares of company stock by 3.70%.